Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02698787 · ClinicalTrials.gov registry record

Fundamental Asynchronous Stimulus Timing Sound Coding Study

A clinical trial of Sensorineural Hearing Loss, sponsored by Cochlear.

Completed
Registry status
11
Enrollment target
1
Study location

NCT02698787 is a study of Sensorineural Hearing Loss that has completed, run by Cochlear. The registered enrollment target is 11 participants, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02698787, a study of Sensorineural Hearing Loss, has completed, sponsored by Cochlear.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The Fundamental Asynchronous Stimulus Timing (FAST) is a novel cochlear implant sound coding strategy. Potential benefits include improved battery life, in addition to improved localization for bilateral patients.

Conditions Studied

Interventions

  • DEVICE Experimental sound coding strategy (FAST)
  • DEVICE Commercially available ACE sound coding strategy

Study Locations (1)

Colorado

  • University of Colorado Health - Aurora

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-12
Est. Completion 2018-11-19

Sponsor

Cochlear

34 total trials

What the Registry Record Tells You About NCT02698787

The ClinicalTrials.gov registry entry for NCT02698787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Experimental sound coding strategy (FAST) is the first listed.

NCT02698787 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02698787 about?

NCT02698787 is a clinical study titled "Fundamental Asynchronous Stimulus Timing Sound Coding Study". The Fundamental Asynchronous Stimulus Timing (FAST) is a novel cochlear implant sound coding strategy. Potential benefits include improved battery life, in addition to improved localization for bilateral patients.

What is the current status of trial NCT02698787?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-12. Estimated completion is 2018-11-19.

What conditions does trial NCT02698787 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss.

What interventions are being tested in trial NCT02698787?

The interventions under investigation include: Experimental sound coding strategy (FAST) (DEVICE), Commercially available ACE sound coding strategy (DEVICE).

Who is sponsoring clinical trial NCT02698787?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02698787 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.